文献速递儿科与产科急症消化、代谢与肾脏急症

儿童血培养阳性时鉴别菌血症与污染菌的临床决策规则的推导与验证:一项回顾性队列研究

Derivation and Validation of a Clinical Rule to Detect Bacteremia Versus Contaminants in Positive Pediatric Blood Cultures: A Retrospective Cohort Study.
PubMed 文献 · Ann Emerg Med · 2025-08-14
一句话结论在加拿大儿童急诊科,基于4项标准的三分类临床决策规则在验证队列中鉴别菌血症的敏感性为99%、特异性为60%,用于初始离院患儿可将住院数从34例降至21例且不漏诊真性菌血症。

研究在加拿大一家儿童急诊科开展,使用2018至2022年(推导队列)和2023至2024年(验证队列)血培养阳性的儿童数据,推导并验证一个鉴别菌血症与污染菌的临床决策规则。推导队列共574例(其中菌血症285例),验证队列共173例(其中菌血症83例),合计747例、菌血症368例。规则基于4项标准将患儿分为高、中、低风险三类,在验证队列中敏感性为99%(95%CI 94至100),特异性为60%(95%CI 50至70)。在验证队列43例初始离院的患儿中应用该规则,可将住院数从34例降至21例,且未漏诊真性菌血症。作者结论认为该规则非常敏感,采用后可能显著影响卫生系统资源。

要点

  • 验证队列中,该临床决策规则鉴别真性菌血症的敏感性为99%(95%CI 94至100),特异性为60%(95%CI 50至70)。
  • 规则基于4项标准将血培养阳性的患儿分为高风险、中风险和低风险三类。
  • 验证队列中43例初始离院的患儿应用该规则后,住院数从34例降至21例,且未漏诊真性菌血症。
  • 推导队列574例中菌血症285例,验证队列173例中菌血症83例,合计747例、菌血症368例。
  • 研究为单中心回顾性队列,作者结论认为采用该规则可能显著影响卫生系统资源。

适用人群与场景

  • 加拿大一家儿童急诊科中血培养阳性的儿童,推导队列为2018至2022年,验证队列为2023至2024年。
  • 推导队列共574例(菌血症285例),验证队列共173例(菌血症83例),合计747例、菌血症368例。

诊断标准与关键阈值

  • 临床决策规则基于4项标准将患儿分为高风险、中风险和低风险三类,用于鉴别菌血症与污染菌。

研究设计与关键结果

  • 研究类型为回顾性队列研究,在加拿大一家儿童急诊科开展,推导队列574例(菌血症285例)、验证队列173例(菌血症83例),合计747例、菌血症368例。
  • 主要结局为菌血症;采用分类与回归树模型推导高敏感性临床决策规则,潜在预测因子来自文献综述和专家共识。
  • 验证队列中规则敏感性为99%(95%CI 94至100),特异性为60%(95%CI 50至70)。
  • 验证队列43例初始离院的患儿中应用该规则,住院数从34例降至21例,且未漏诊真性菌血症。

证据类型、等级与局限

  • 证据类型为回顾性队列研究,原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,该规则非常敏感,可用于识别血培养阳性儿童中的菌血症;采用该规则可能显著影响卫生系统资源。
  • 在验证队列43例初始离院的患儿中,应用该规则可将住院数从34例降至21例,且未漏诊真性菌血症。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVES: Fifty percent of positive blood cultures in the pediatric emergency department (ED) are contaminants. We derived and validated a clinical decision rule discriminating bacteremia from contaminants among children seen in the ED with a positive blood culture.

METHODS: We used 2 cohorts of children with positive blood cultures from a Canadian pediatric ED in 2018 to 2022 (derivation) and 2023 to 2024 (validation). The primary outcome was bacteremia. Potential predictors of bacteremia were derived from a literature review and experts' consensus. We used Classification and Regression Tree models to derive a highly sensitive clinical decision rule. The validity was assessed by measuring the proportion of children with true bacteremia classified at high or moderate risk by the clinical decision rule (sensitivity) and the proportion of contaminants classified at low risk (specificity). The clinical utility was measured by comparing the clinical decision rule to the treating physician's management.

RESULTS: A total of 747 children, including 368 cases of bacteremia were included in the derivation (total 574; 285 bacteremia) and validation (total 173; 83 bacteremia) cohorts. The clinical decision rule classifies children into 3 categories (high, moderate, and low risk) based on 4 criteria. It demonstrated a sensitivity of 99% (95% confidence interval [CI] 94 to 100) and a specificity of 60% (95% CI 50 to 70) in the validation cohort. Using the clinical decision rule among the 43 children initially discharged in the validation cohort would decrease the number of hospitalizations from 34 to 21 without missing a true bacteremia.

CONCLUSION: We created a very sensitive clinical decision rule to identify bacteremia in children with positive blood culture. Adopting this clinical decision rule could significantly impact health system resources.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Gravel J, Grandjean-Blanchet C, Loghin AD, et al. Derivation and Validation of a Clinical Rule to Detect Bacteremia Versus Contaminants in Positive Pediatric Blood Cultures: A Retrospective Cohort Study. Ann Emerg Med. 2025. PMID: 40810705. doi:10.1016/j.annemergmed.2025.06.620

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。